Peak Proteins Company News Archives
Two Peak/Sygnature scientists, Juli Warwicker and Mark Abbott, have recently co-authored a paper on a new family of anti-thrombotic biotherapeutics. The paper is from the lab of Dr. Yotis Senis, Research Director, INSERM, Strasbourg, France. The Senis lab have [...]
We are delighted to announce that our new HPLC-FSEC / SEC-MALS platform is now up and running. We've chosen an Agilent BioInert HPLC system with a number of detectors, allowing us to monitor proteins by UV absorbance, fluorescence, and [...]
Last week a group of 15 sixth form students from All Hallows Catholic College came to visit Peak Proteins as part of their NCS (National Citizen Service) programme to help grow their employability skills. The afternoon was organised by [...]
At the recent FidaBio US User Group Meeting held in Boston, Duncan Smith was invited to give a talk highlighting how the Fida technology has had an impact on several of our recent drug discovery projects. For the last [...]
Sygnature Discovery is delighted to welcome Rachel Johnson to the Peak Proteins team. Rachel’s arrival highlights our commitment to offering our clients an exceptional Cryo-EM and structural biology service. Rachel has determined >20 cryo-EM structures of GPCRs allowing her [...]
As you will recall, Peak Proteins were acquired by Sygnature Discovery in April 2022. Now, that Sygnature have subsequently completed the acquisition of NuChem Sciences and their subsidiaries IniXium and OmegaChem in July this year, we are delighted to [...]
In the spirit of International Microorganisms Day (17th September) we have been inspired to enter the highly competitive American Society for Microbiology agar art contest, this year based on the theme “Microbiology in Space”. With our site based in [...]
It is 9 years since the formation of Peak Proteins and in July this year, with the arrival of Ariadna Juarez-Martinez, we reached 50 people. 50 people, all under one roof, all focused on protein science and structural biology [...]
Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug [...]
At Peak Proteins we firmly believe in the transformative power of scientific education and inspiring young minds. While our primary role revolves around providing support for our client projects, we have also embarked on a journey of scientific outreach with [...]
Peak Proteins
Birchwood House,
Larkwood Way,
Macclesfield,
Cheshire, SK10 2XR
Phone us + 44 (0)115 9415401
Email us: info@peakproteins.com
Peak Proteins is a trading name of Sygnature Discovery Limited
